Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
life sciences
national blog main
national top stories
sickle cell disease
3
×
boston
boston top stories
crispr
deals
fda
gilead sciences
new york blog main
new york top stories
san francisco blog main
san francisco top stories
startups
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
azacitidine
beta-thalassemia
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
cystic fibrosis
cystic fibrosis foundation
dacogen
decitabine
What
medicines
3
×
step
acquisitions
aims
announced
approach
based
bio
biotech
called
ceo
cf
collabs
covid
crisis
cystic
daniel
deal
debuts
developer
developing
drugs
epigenetic
epigenetics
fibrosis
field
flagship’s
force
gilead
gilead’s
help
helped
introduce
ipo
jeff
leiden
month
morning
new
omega
Language
unset
unknown
Current search:
medicines
×
biotech
×
" sickle cell disease "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles